Static Chart CEL-SCI Corporation

Equities

Delayed Nyse Other stock markets 14:20:05 2024-05-28 EDT			5-day change	1st Jan Change
1.27 ^USD	+3.26%		-3.05%	-53.31%

05-08	Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine	MT
05-08	CEL-SCI Corporation Announces Significantly Positive Outcome from its Recent Meeting with U.S. Food and Drug Administration Regarding Path to Approval for its First-Line Investigational Cancer Immunotherapy Multikine	CI

Duration

Period